Term
|
Definition
presence of bacteria in blood (positive blood cultures) |
|
|
Term
def. systemic inflammatory response syndrome |
|
Definition
|
|
Term
|
Definition
- infection with SIRS (usually positive blood cultures)
|
|
|
Term
|
Definition
sepsis with hypotension or evidence of altered organ perfusion/dysfunction |
|
|
Term
|
Definition
sepsis syndrome with hypotension despite fluid resuscitation |
|
|
Term
multiple organ dysfunction |
|
Definition
- altered organ function in an acutely ill pateints
- homeostasis cannot be maintained without intervention
|
|
|
Term
predisposing factors for bacteremia |
|
Definition
- violate mechanical barriers
- IV, intraarterial catheters
- endotracheal intubation
- urethral catheters
- surgical wounds
- invasive procedures
- obstruction of a viscus- prolif. usually proximal to obstruction with escape into blood stream
- impaired host defense mechanisms
- cytotoxic chemotherapy
- immunodeficiencies
- prior antibiotic therapy changing microbial flora
|
|
|
Term
Prevelance of bacteremia in gram pos. and gram negative |
|
Definition
- gram positive has become more common than gram negative
- Staph the most common
- coagulase negative staph cause bactermia in patients with indwelling IV catheters
|
|
|
Term
Gram neg. organism most common cause for bacteremia. Name some other common causes of bacteremia that are gram negative organisms |
|
Definition
-
E coli
-
other enterobacteria
|
|
|
Term
Common Sites of infection with bacteremia |
|
Definition
- urinary tract
- lung (most common for severe infection)
- intraabdomnial source (second most common source for severe infection)
|
|
|
Term
Hemodynamic effects in sepsis/endotoxemia |
|
Definition
- drop in afterload aka drop in systemic vascular resistance (due to vasodilation)
- characteristic hemodynamic feature in septic shock
- allows heart to pump greater volume, so CO and EF increase
- however, vascular bed so dilated that the heart cant keep up with the demand
- endotoxins will also decrease myocardial contractility
- In the end, the CO cant keep up with the increased demands caused by the drop in SVR, leads to hypotension
|
|
|
Term
Mech. of action of endotoxin causing humoral effects
|
|
Definition
- endotoxin initiate complement cascade via the O polysac. (alternative path) or lipid A (classical pathway) leading to inflammation
- initiates kinin pathway to produce bradykinin leading to hypotension
- activates Hageman factor (via TNF damaged endothelial cells or directly) initiates coagulation pathway and fibrinolytic pathway leading to disseminated intravascular coagulation (DIC)
|
|
|
Term
Cells affected by endotoxin |
|
Definition
- macrophages and monocytes
- lymphocytes
- neutrophils
- endothelial cells
|
|
|
Term
Products of endothelial cells upon being stimulated by endothelial cells |
|
Definition
- IL-1- cause fever
- IL-6
- NO- vasodilator
|
|
|
Term
Products produced by neutrophil upon stimulatino by endotoxin |
|
Definition
- prostaglandins
- leukotrienes
- superoxide
|
|
|
Term
Products produced by macrophages upon stimulation by endotoxin |
|
Definition
- IL-1
- IL-6
- IL-8
- IL-12
- TNF alpha
- IFN alpha
- G-CSF
- beta chemokines
|
|
|
Term
Products stimulated to be produced in lymphocytes by endotoxin |
|
Definition
- IL-2
- IL-3
- IL-4
- IL-6
- IL-10
- IL-13
- IFN gamma
- GM-CSF
|
|
|
Term
Earliest host mediators activated via endotoxin |
|
Definition
|
|
Term
Experiments prooving that endotoxin biological effects are due to host mediators or cytokines |
|
Definition
- bone marrow transplants between endotoxin sensitive and resistant mice can change endotoxin sensitivity
- endotoxin sensitive mice can be made endotoxin resistant via bone marrow transplant
- reticuloendothelial hyperplasia leads to increased endotoxin sensitivity
- remember, TNF produced by endothelial cells
- supernatant from bone marrow cell culture of endotoxin stimulated macrophages obtained from endotoxin sensitive mice will cause shock and death in endotoxin resistant mice
- direct TNF injection lead to shock
- TNF produced by macrophages is in bone marrow
|
|
|
Term
Mech. of gram positive septic shock |
|
Definition
- toxins are superAg
- they will stimulate T cells to release cytokines
|
|
|
Term
PAMP's and their role as endogenous mediators of effects of endotoxins |
|
Definition
- sensed by TLR's as a mechanism for recognition of pathogens and presentation to cells
- ligands can be LPS, techoic acid, or any conserved microbial molecule
- Process
- LPS bind to LPS binding protein which binds to CD14 on phagocytic cells
- CD14 passes LPS to TLR, leading to activating the transcription factor nF-κB, signal transduction, and cytokine synthesis
|
|
|
Term
|
Definition
|
|
Term
Effect of C5a and its role in devlopment of ARDS |
|
Definition
- C5a will cause neutrophil agglutination and trapping of these clumps in the lungs
- in the lung, they cause production of oxygen radicals and lysosomal enzyme release that can damage endothelial cells
- if there is damage to the lung capilaries, we get ARDS
|
|
|
Term
Aside from C5a, what are the roles of other cell mediators in the development of ARDS |
|
Definition
Remember, this is pulmonary complication of severe sepsis/shock
|
|
|
Term
Compare the general effect on the body of cytokine in high and low concentrations. What does this mean in terms of how we treat sepsis? |
|
Definition
- low- beneficial
- high- detrimental
Control the cytokine storm to take care of sepsis. |
|
|
Term
Pathogenesis of septic shock. how do we treat at each stage of development? |
|
Definition
- beginning of infection
- blood stream infection
- neutralize microbial toxins
- activation of mediators
- shock and multiorgan failure
|
|
|
Term
What we can do to neutralize the microbial toxins? |
|
Definition
- anti-endotoxin Ab's
- monoclonal Ab's directed against TNF
- soluble TNF R's
- bind TNF and prevent it from reaching bioactive receptors on cell
|
|
|
Term
What can we do to modulate the host response to bacteremia? |
|
Definition
- glucocorticosteroids (high and low dose)
- IL-1 R antagonist
- monoclonal antibody to TNF
- anti CD14
- NO antagonists
- ibuprofen
|
|
|
Term
mechanism of development of disseminated inravascular coagulation |
|
Definition
- systemic activation of coagulation
- leads to:
- intravascular depostion of fibrin causing microvascular thrombosis of small and midsized vessels causing organ failure (ischemia, infarction)
- depletion of platelet and coagulation factors, causing bleeding
|
|
|
Term
Low levels of what endogenous compounds are associated with the development of DIC? What is their function? |
|
Definition
- antithrombin 3
- inh. vitamin K dependent proteases (factors IX, X)
- activated protein C
- inactivate factors V, VII
This is caused by a prolonged consumption leading to sustained procoagulant effect, causing inh. of fibrinolysis. |
|
|
Term
Treatment/prevention of DIC associated with bacteremia. Prognosis after treatment |
|
Definition
- treat with activated protein C
- prognosis- improvement in DIC and reduced mortality
|
|
|
Term
Problems with attempting immune modulation of sepsis by blocking proinflam. cytokines |
|
Definition
- overproduction of proinflam. cytokines leads to an immunosuppresed response
- we keep failing because we also will produce an immunosuppressive response
- dominant cytokines in blood of septic pateints are antiinflammatory such as
- IL-4 (makes Th2 and produced by Th2)
- IL-10 (downregulates IL-1, 6, TNF alpha, IFN gamma, and promotes Th2 response)
THIS IS WHY THESE BACTERIA SURVIVE |
|
|
Term
pathogenesis of septic shock |
|
Definition
- primary role of cytokines and chemokines is to localize and contain infection
- sepsis represents a system that is out of control
- the primary generalized host response is an attempt to down regulate inflammation
|
|
|
Term
components of acute phase response in sepsis |
|
Definition
- anti-infective (release complement, PRM's, sequester Fe)
- anti-inflam (cytokine antagonists, steroids, antioxidants, protease inh.)
- procoagulant (wall of infection
- metabolic (mobilize fatty acids, maintain normal glucose)
|
|
|
Term
Role of IL-6 in acute phase response to sepsis |
|
Definition
- cellular SOS signal
- epi induce IL-6 production in vivo
- infusion of IL-6 raise blood levels of IL-4, IL-1, cortisol
- IL-6 stimulate hypothalamic pit. axis
- IL-6 knockout mice have exagerated responses to bacterial challenge
|
|
|
Term
Dose dependent effects of cortisol on acute phase response to sepsis |
|
Definition
- at normal concentrations, it allows for synthesis of acute phase pro-inflam. proteins
- at high conc., it suppreses these proteins and stimulates anti-inflam proteins like IL-10
- downreg. IL-1, IL-6, TNF, and IFN gamma
|
|
|
Term
Mechanism of T cell immunosuppresion in sepsis |
|
Definition
- in later stages of sepsis, there is a shift from proinflam. Th1 response to anti inflam. Th2 response
|
|
|
Term
non lymphocytic mechanism of sepsis causing immunosuppresion |
|
Definition
- state of anergy
- promotes apoptosis, leading to an anti inflammatory response
- if necrosis, this would enhance antimicrobial defenses
- evidence- protease inhibitors will inhibit caspases, hence inhibit apoptosis, leading to improved survival in experimental sepsis by modulating production of pro and anti inflammatory cytokines (everything calms down)
|
|
|
Term
Clincal manifestation of sepsis: resp., renal, GI, hepatic, hematologic |
|
Definition
- resp.- acute lung injury w/tachypnea and resp. alkalosis which can become ARDS
- renal- acute tubular necrosis secondary to hypotension
- GI- bacterial translocation due to apoptosis of mucosal cells
- hepatic dysfunction in two forms
- cholestasis with decreased billirubin excretion
- if shock severe, hepatocellular cell necrosis and liver failure
- hematologic
- leukocytosis (if leukopenia, more severe)
- thrombocytopenia (due to DIC or IgG)
- coagulopathy
|
|
|
Term
CV effects of severe sepsis |
|
Definition
|
|
Term
Metabolic clinical manifestations of severe sepsis |
|
Definition
- glucose increased (increased gluconeogenesis in liver)
- lipids
- decrease syn. of cholesterol
- TNF inh. of lipoprotein lipase
- increased lactate due to decreased tissue perfusion and acidosis
|
|
|